Skip to content

Development of Key Technologies for Three-Tier Assessment and Deep Reasoning Large Models Related to Intracranial Atherosclerotic Stenosis-Associated Cognitive Impairment

Development of Key Technologies for Three-Tier Assessment and Deep Reasoning Large Models Related to Intracranial Atherosclerotic Stenosis-Associated Cognitive Impairment

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500109350
Enrollment
Unknown
Registered
2025-09-17
Start date
2025-09-17
Completion date
Unknown
Last updated
2025-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial atherosclerosis

Interventions

Observation group:none

Sponsors

Peking Union Medical College Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age 18-85 years; 2. Confirmed by MRA or CTA, carotid atherosclerotic stenosis of the Willis ring (less than 50%, greater than or equal to 50%, or occlusion); 3. mRS score <= 2 points; 4. No stroke or TIA, or more than 3 months since onset of stroke or TIA.

Exclusion criteria

Exclusion criteria: 1.Extracranial cervical artery stenosis > 50%; 2.Relative/absolute contraindications related to MRI safety (e.g., metallic implants, claustrophobia); 3.Clinically confirmed non-atherosclerotic causes of intracranial stenosis, such as dissection, vasculitis, moyamoya disease, embolism, or immune-mediated diseases; 4.Other confirmed etiological subtypes of stroke, including cerebral hemorrhage, subarachnoid hemorrhage, or cardioembolism; 5.Clinically diagnosed neurodegenerative disorders, such as Alzheimer’s disease, Lewy body dementia, frontotemporal lobar degeneration, or Parkinson’s disease; 6.Other comorbid medical histories that may interfere with endpoint event judgment and follow-up, including history of traumatic brain injury, multiple sclerosis, encephalitis, tumor, poisoning, syphilis, or severe cardiac, pulmonary, hepatic, renal, or endocrine diseases; 7.Refusal to sign informed consent; 8.Pregnant or lactating women will not be included in the PET/MRI substudy.

Design outcomes

Primary

MeasureTime frame
stroke event;cognitive status;

Secondary

MeasureTime frame
multimodel imaging index;Modified Rankin Scale (MRS) Score;Domain-specific Z-scores (Memory, Attention, Executive Function, Visuospatial, Language);blood biomarker;Comprehensive Z-scores of neuropsychological scales;Hamilton anxiety and depression scale;

Countries

China

Contacts

Public ContactCaiyan Liu

Peking Union Medical College Hospital

liucy-pumch@163.com+86 10 69151360

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026